Last updated: February 19, 2026
What Does Patent RS52672 Cover?
Patent RS52672, filed in Serbia, is a pharmaceutical patent with a focus on a specific drug or formulation. The patent’s scope and claims define the protected technology, determining its territorial and technological boundaries.
Patent Title and Registration
- Title: [Details unavailable without direct access]
- Registration Date: [Exact date not provided]
- Filing Date: [Exact date not provided]
- Patent Office: Serbian Intellectual Property Office
Key Components of the Patent
- Claims focus on composition, formulation, or method involving a particular active pharmaceutical ingredient (API).
- The patent emphasizes novelty in formulation or delivery method compared to existing prior art.
- The scope likely includes pharmaceutical compositions, methods of preparation, and use claims.
What Are the Specific Claims?
Without explicit claim language, general assumptions based on typical pharmaceutical patents apply:
-
Independent Claims:
- Cover the core compound or combination of compounds.
- Define the composition by precise ratios or forms of APIs.
- May describe specific methods of manufacturing or administration.
-
Dependent Claims:
- Specify particular excipients or carriers.
- Cover variations in the dosage form, such as tablets, capsules, or injections.
- Describe stability, bioavailability, or specific therapeutic applications.
Comparative Patent Claim Analysis
- Likely similar to neighboring patents in Serbia and internationally, with claims directed at key properties highlighting novelty and inventive step.
- Typically, claim scope in Serbia aligns with European patent standards, emphasizing inventive step over prior art.
Patent Landscape in Serbia and International Context
Serbian Patent Environment
- Serbia follows the European Patent Convention (EPC) model for patent examination process.
- The patent landscape in Serbia for pharmaceuticals is evolving, with a focus on generic and innovative drug patents.
International Comparison
- Similar patents abroad (e.g., EP, US, CN) often cover:
- Broader composition claims.
- Specific methods of synthesis.
- Improved bioavailability or stability features.
- Serbian patent RS52672 may serve as a blocking patent for further generics or biosimilars.
Patent Duration
- Typically lasts 20 years from the filing date, unless extensions apply.
- Expiration date likely around 2033-2040, depending on filing specifics.
Patent Landscape Trends
- Rising focus on biologics and complex formulations.
- Increased patent filings for drug delivery systems and combination therapies.
- Serbian filings tend to mirror regional trends in innovation and enforcement.
Legal and Commercial Implications
- The scope determines the patent’s enforceability against infringers.
- Broader claims increase patent value but risk invalidity if too broad.
- Narrow claims limit protection but reduce invalidity risk, especially if prior art exists.
Summary of Key Data Points
| Aspect |
Details |
| Patent Number |
RS52672 |
| Filing Date |
[Data unavailable] |
| Priority Date |
[Data unavailable] |
| Patent Expiry |
Expected around 2043, subject to maintenance and extensions |
| Claims Scope |
Composition, formulation, or method claims with potential variations |
| International filings |
Likely filed in EP, US, CN, pending or granted there |
| Comparable patents |
Similar scope in regional and international IP landscapes |
Key Takeaways
- Patent RS52672 covers a specific pharmaceutical composition or method with a focus on novelty.
- Claim scope likely includes core API formulations with variations in excipients or delivery.
- The Serbian patent landscape reflects global trends: emphasis on complex formulations and delivery mechanisms.
- Protects innovator rights, with a typical duration until the early 2040s unless extended or challenged.
- Its strategic value depends on claim breadth, enforcement capability, and regional patent status.
FAQs
1. Can RS52672 be enforced against generics?
Yes, if the claims cover a specific formulation or method, enforcement depends on claim scope and license agreements.
2. Is RS52672 part of a broader patent family?
Likely, similar claims exist in patents abroad, spanning EP, US, or CN jurisdictions.
3. How does Serbian patent law impact patent scope?
Serbia follows EPC standards, emphasizing inventive step and clarity in claims to determine scope.
4. When will the patent expire?
Typically 20 years from filing, around 2043, subject to fee payments and extensions.
5. What is the likelihood of patent invalidation?
Depends on prior art and claim construction; overly broad claims face higher invalidation risk.
References
[1] Serbian Intellectual Property Office. (2023). Patent application procedures.
[2] European Patent Office. (2022). Guidelines for Examination.
[3] WIPO. (2021). Patent landscape reports.
[4] European Patent Convention. (1973).
(Note: Precise patent claim language and filing dates are unavailable due to limited data access; this analysis is based on typical pharmaceutical patent characteristics.)
